Your browser doesn't support javascript.
loading
Parabens and Menopause-Related Health Outcomes in Midlife Women: A Pilot Study.
Pacyga, Diana C; Chiang, Catheryne; Li, Zhong; Strakovsky, Rita S; Ziv-Gal, Ayelet.
Afiliação
  • Pacyga DC; Department of Food Science and Human Nutrition, Michigan State University, East Lansing, Michigan, USA.
  • Chiang C; Institute for Integrative Toxicology, Michigan State University, East Lansing, Michigan, USA.
  • Li Z; Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
  • Strakovsky RS; Metabolomics Lab, Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
  • Ziv-Gal A; Department of Food Science and Human Nutrition, Michigan State University, East Lansing, Michigan, USA.
J Womens Health (Larchmt) ; 31(11): 1645-1654, 2022 11.
Article em En | MEDLINE | ID: mdl-35787012
Background: Parabens are antimicrobial agents prevalently found in daily-use products that can interfere with the endocrine and reproductive systems. In this study, we examined the cross-sectional associations of parabens with hot flashes, hormone concentrations, and ovarian volume in a subsample of 101 nonsmoking, non-Hispanic 45- to 54-year-old women from the Midlife Women's Health Study. Materials and Methods: Women self-reported their hot flash history and underwent a transvaginal ultrasound to measure ovarian volume. Participants provided blood for quantification of serum hormones (by enzyme-linked immunosorbent assay or radioimmunoassay) and urine samples for measurements of urinary paraben biomarker levels (by high-performance liquid chromatography negative-ion electrospray ionization-tandem mass spectrometry). Linear or logistic regression models evaluated associations of specific gravity-adjusted paraben biomarker concentrations with hot flashes, hormone concentrations, and ovarian volume. Results: We observed marginal associations of propylparaben, methylparaben, and ∑parabens biomarkers (molar sum of four parabens) with hot flashes and follicle-stimulating hormone (FSH) concentrations, and of these paraben biomarkers and ethylparaben with ovarian volume. For example, women tended to have 32% (95% confidence intervals [CI]: 0.9 to 1.81), 40% (95% CI: 1.0 to 1.95), and 40% (95% CI: 0.98 to 2.01) higher odds of having recent, monthly, and mild hot flashes, respectively, for every two-fold increase in ∑parabens. Similarly, women tended to have 14.54% (95% CI: -0.10 to 31.32) higher FSH concentrations, but 5.67% (95% CI: -12.54 to 1.75) reduced ovarian volume for every two-fold increase in ∑parabens Conclusions: Overall, our preliminary findings suggest that urinary paraben biomarkers may be associated with menopause-related outcomes in midlife women. Additional studies in larger and diverse populations are needed to expand on these findings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Parabenos / Menopausa / Fogachos Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: J Womens Health (Larchmt) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Parabenos / Menopausa / Fogachos Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: J Womens Health (Larchmt) Ano de publicação: 2022 Tipo de documento: Article